Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Evgen Pharma ( (GB:TCF) ) has issued an announcement.
TheraCryf PLC, a company listed on the stock exchange, has announced a change in its major holdings. Andrew Leach has acquired a significant portion of voting rights, totaling 3.7565%, as of March 11, 2025. This acquisition could influence the company’s decision-making process and potentially impact its strategic direction.
More about Evgen Pharma
YTD Price Performance: -57.14%
Average Trading Volume: 2,247,055
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £4.79M
See more insights into TCF stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue